Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries — Stella

Recruiting

Back to Angina Pectoris trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Stanford Hospital, Palo Alto, California

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Stanford University

Collaborators

American Heart Association

Enrollment target

~150 participants

Started

October 2024

Primary completion

December 2026

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov